Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial -

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial
Information type: Randomised controlled trials
Source: Lancet Public Health
Specialities: Haematological disorders | Obstetrics and gynaecology
Summary
Antepartum prophylactic dalteparin did not reduce occurrence of VTE, pregnancy loss, or placenta-mediated pregnancy complications in pregnant women with thrombophilia at high risk of these complications and was associated with an increased risk of minor bleeding (n=289).
UKMi comment

The following resource may also be of interest.
Related links: Comment – full text (access to subscribers only)